Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Samsung Biologics signs manufacturing deal with European pharmaceutical company 2024-11-20 07:23
Samsung Biologics earns ISO certifications in recognition of business excellence 2024-11-08 20:00
Samsung Biologics reports third quarter 2024 financial results 2024-10-23 14:55
Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development 2024-10-14 19:00
Samsung Biologics launches development platforms for enhanced therapeutic efficacy 2024-09-25 19:00
Samsung Biologics joins the Pharmaceutical Supply Chain Initiative as Supplier Partner 2024-08-06 19:00
Samsung Biologics Reports First Quarter 2024 Financial Results 2024-04-24 14:45
Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture an antibody cancer drug substance 2023-09-18 07:57
Samsung Biologics appoints new leadership to oversee quality and regulatory affairs 2023-08-24 07:59
Samsung Biologics Reports Second Quarter 2023 Financial Results 2023-07-26 15:23
Samsung Biologics releases 2023 ESG Report, reaffirming its commitment to net-zero progress and corporate social responsibility 2023-07-18 19:00
Samsung Biologics accelerates timeline of new fifth plant to be operational by April 2025 2023-06-06 19:00
Samsung Biologics Reports First Quarter 2023 Financial Results 2023-04-24 14:51
Samsung Biologics announces construction of Plant 5 to commence Bio Campus II capacity expansion 2023-03-17 19:25
Samsung Biologics Reports Fourth Quarter & Fiscal Year 2022 Financial Results 2023-01-27 14:52
Samsung Biologics receives the Terra Carta Seal in recognition of the company's commitment to creating a sustainable future 2023-01-11 08:01
Samsung Biologics Reports Third Quarter 2022 Financial Results 2022-10-27 07:35
Samsung Biologics obtains three global ISO certifications 2022-10-13 19:00
Samsung Biologics unlocks additional capacity for production at its newest Plant 4 2022-10-11 19:00
Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™ at BPI Boston 2022 2022-09-29 19:00
1 2 3 4 5